<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>158(2)</volume><submitter>Mesnage R</submitter><pubmed_abstract>Plasticizers with estrogenic activity, such as bisphenol A (BPA), have potential adverse health effects in humans. Due to mounting evidence of these health effects, BPA is being phased out and replaced by other bisphenol variants in "BPA-free" products. We have compared estrogenic activity of BPA with 6 bisphenol analogues [bisphenol S (BPS); bisphenol F (BPF); bisphenol AP (BPAP); bisphenol AF (BPAF); bisphenol Z (BPZ); bisphenol B (BPB)] in 3 human breast cancer cell lines. Estrogenicity was assessed (10-11-10-4 M) by cell growth in an estrogen receptor (ER)-mediated cell proliferation assay, and by the induction of estrogen response element-mediated transcription in a luciferase assay. BPAF was the most potent bisphenol, followed by BPB > BPZ ∼ BPA > BPF ∼ BPAP > BPS. The addition of IC</pubmed_abstract><journal>Toxicological sciences : an official journal of the Society of Toxicology</journal><pagination>431-443</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5837682</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Editor's Highlight: Transcriptome Profiling Reveals Bisphenol A Alternatives Activate Estrogen Receptor Alpha in Human Breast Cancer Cells.</pubmed_title><pmcid>PMC5837682</pmcid><pubmed_authors>Balu S</pubmed_authors><pubmed_authors>Antoniou MN</pubmed_authors><pubmed_authors>Phedonos A</pubmed_authors><pubmed_authors>Arno M</pubmed_authors><pubmed_authors>Mesnage R</pubmed_authors><pubmed_authors>Corton JC</pubmed_authors></additional><is_claimable>false</is_claimable><name>Editor's Highlight: Transcriptome Profiling Reveals Bisphenol A Alternatives Activate Estrogen Receptor Alpha in Human Breast Cancer Cells.</name><description>Plasticizers with estrogenic activity, such as bisphenol A (BPA), have potential adverse health effects in humans. Due to mounting evidence of these health effects, BPA is being phased out and replaced by other bisphenol variants in "BPA-free" products. We have compared estrogenic activity of BPA with 6 bisphenol analogues [bisphenol S (BPS); bisphenol F (BPF); bisphenol AP (BPAP); bisphenol AF (BPAF); bisphenol Z (BPZ); bisphenol B (BPB)] in 3 human breast cancer cell lines. Estrogenicity was assessed (10-11-10-4 M) by cell growth in an estrogen receptor (ER)-mediated cell proliferation assay, and by the induction of estrogen response element-mediated transcription in a luciferase assay. BPAF was the most potent bisphenol, followed by BPB > BPZ ∼ BPA > BPF ∼ BPAP > BPS. The addition of IC</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Aug</publication><modification>2026-04-07T19:32:43.89Z</modification><creation>2019-03-26T23:06:54Z</creation></dates><accession>S-EPMC5837682</accession><cross_references><pubmed>28591870</pubmed><doi>10.1093/toxsci/kfx101</doi></cross_references></HashMap>